Philip W Woodward1, Christine Williams, Andreas Sewing
1Non-Clinical Statistics Group, Pfizer Development Operations, Sandwich, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Comparing novel drug discovery screening methods reveals lower than expected concordance, even when methods are compared to themselves. Statistical modeling helps understand assay variability and optimize experimental designs for reliable results.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: